Regal Healthcare Capital Partners closes Fund IV at $610 million, surpassing fundraising target
NEW YORK, July 7. Regal Healthcare Capital Partners closed its fourth private equity fund at $610 million, above the firm's stated fundraising target, the New York-based firm announced. The fund, RHCP IV, is directed exclusively toward healthcare services company investments.
Key takeaways
- Regal Healthcare Capital Partners closed its fourth private equity fund, RHCP IV, at $610 million.
- The $610 million final close exceeded the firm's stated fundraising target.
- RHCP IV invests exclusively in healthcare services companies.
- The final close was announced July 7, 2026 by the New York-based firm.
- The announcement did not disclose the original target amount or the margin by which it was surpassed.
NEW YORK, July 7. Regal Healthcare Capital Partners closed its fourth private equity fund at $610 million, above the firm's stated fundraising target, the New York-based firm announced. The fund, RHCP IV, is directed exclusively toward healthcare services company investments.
Above-target close
The final close of RHCP IV was announced July 7, 2026. At $610 million, the fund exceeded the target Regal set when it opened the raise. The announcement did not specify the original target amount or the margin by which the final close surpassed it.
Firm profile
Regal Healthcare Capital Partners is based in New York and limits its investment mandate exclusively to healthcare services companies, the firm said. RHCP IV is the fourth private equity fund in Regal's series. The $610 million final close concludes the fundraising period for the vehicle.